ストックスクリーナーアプリを入手
12.93
0.19%
-0.025
前日終値:
$12.95
開ける：
$12.33
24時間の取引高:
300
Relative Volume:
0.06
時価総額：
$103.41M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-4.26%
1か月 パフォーマンス:
+4.23%
6か月 パフォーマンス:
+18.58%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$12.33
$12.33
1週間の範囲:
$12.33
$14.00
52週間の値動き範囲:
$8.86
$22.63
Exozymes Inc Stock (EXOZ) Company Profile
EXOZ を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EXOZ
Exozymes Inc
|
12.33 | 108.61M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.60 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.54 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.70 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.41 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Exozymes Inc (EXOZ) 最新ニュース
Real time pattern detection on eXoZymes Inc. stockExit Point & Momentum Based Trading Ideas - newser.com
eXoZymes Inc. stock trendline breakdownJuly 2025 Fed Impact & Safe Swing Trade Setup Alerts - newser.com
eXoZymes Inc.’s volatility index tracking explainedMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Is eXoZymes Inc. stock entering bullish territoryWeekly Investment Summary & Growth Oriented Trade Recommendations - newser.com
eXoZymes (NASDAQ:EXOZ) Receives “Sell (E+)” Rating from Weiss Ratings - Defense World
Relative strength of eXoZymes Inc. in sector analysisQuarterly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
Full technical analysis of eXoZymes Inc. stockJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
What high frequency data says about eXoZymes Inc.Inflation Watch & Weekly Momentum Stock Picks - newser.com
eXoZymes Unveils Updated Investor Presentation - TipRanks
Why analysts upgrade eXoZymes Inc. stockMarket Growth Report & Daily Volume Surge Signals - newser.com
Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees - ACCESS Newswire
Cell-Free Biomanufacturing Pioneer eXoZymes Gains Strategic Positions in Federal Innovation Institute - Stock Titan
What analysts say about eXoZymes Inc stockVolatility Adjusted Trading & Free Robust Financial Gains - earlytimes.in
HCM II Acquisition Corp Stock Analysis and ForecastStock Price Divergence & Low Risk Wealth Building - earlytimes.in
Multi asset correlation models including Walgreens Boots Alliance Inc.2025 Trading Volume Trends & Growth-Oriented Investment Plans - newser.com
How hedge fund analytics apply to RDDT stock2025 Retail Activity & Daily Momentum Trading Reports - newser.com
Why Encres Dubuit (1F2) stock is a strong buy callStop Loss & Fast Momentum Entry Tips - newser.com
Why National Bank of Canada (NBC) stock could be next leaderPortfolio Gains Summary & Target Return Focused Stock Picks - newser.com
Can FTI Consulting Inc. (FCQ) stock surprise with quarterly resultsWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Is Ponsse Oyj (PNS) stock a buy before earnings resultsLayoff News & Growth Focused Stock Reports - newser.com
Is Roman DBDR Acquisition Corp. II Equity Warrant stock a buy on dipsJuly 2025 Intraday Action & Daily Entry Point Alerts - newser.com
Is Owlet Inc. stock a good choice for value investorsSell Signal & Safe Entry Trade Reports - newser.com
Is MGR stock supported by free cash flow2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
How to recover losses in Falcon s Beyond Global Inc. stockJuly 2025 Update & Low Drawdown Trading Techniques - newser.com
Will HAL Trust (HA4) stock benefit from Fed rate cutsQuarterly Profit Review & Short-Term High Return Strategies - newser.com
Why Tradeweb Markets Inc. stock attracts high net worth investorsJuly 2025 Price Swings & High Conviction Trade Alerts - newser.com
Is ITOCHU Corporation (IOC) stock bottoming after sell offBuy Signal & Fast Moving Stock Watchlists - newser.com
Why China Resources Pharmaceutical Group Limited (640) stock is a strong analyst pickMarket Weekly Review & Free High Accuracy Swing Entry Alerts - newser.com
Is eXoZymes Inc a good long term investmentInsider Selling Patterns & High Yield Trading Alerts - Early Times
D pipelineTrade Entry Summary & Proven Capital Preservation Methods - newser.com
Is ARLU stock attractive for dividend growth2025 Market Trends & Detailed Earnings Play Strategies - newser.com
HEICO Corporation stock volume spike explainedWeekly Gains Summary & Growth Oriented Trading Recommendations - newser.com
How high can eXoZymes Inc. stock goJuly 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com
Exozymes Inc (EXOZ) 財務データ
Exozymes Inc (EXOZ) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Exozymes Inc (EXOZ) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Heltzen Michael | Chief Executive Officer |
Jan 17 '25 |
Buy |
10.78 |
1,767 |
19,048 |
3,872 |
| Heltzen Michael | Chief Executive Officer |
Jan 16 '25 |
Buy |
10.72 |
121 |
1,297 |
2,105 |
| Heltzen Michael | Chief Executive Officer |
Nov 15 '24 |
Buy |
11.10 |
1,984 |
22,022 |
1,984 |
1.24%
大文字化:
|
ボリューム (24 時間):